S3989 Proctitis as an Unusual Presentation of Mast Cell Activation Syndrome

Introduction: Mast cell activation syndrome (MCAS) is a condition characterized by the excessive activation of mast cells, leading to the release of mediators such as histamine, tryptase, and prostaglandins. MCAS typically affects at least 2 systems, including dermatologic (flushing, urticaria, pruritus), gastrointestinal (abdominal pain, diarrhea, nausea), cardiovascular (hypotension, tachycardia, syncope), and respiratory (wheezing, dyspnea). We present an interesting case of MCAS with an unusual presentation of proctitis on endoscopy, where symptoms resolved with antihistamine therapy. Case Description/Methods: A 52-year-old woman with a history of multiple episodes of anaphylaxis of unclear etiology presented to the clinic for evaluation of abdominal pain and diarrhea that had persisted for one year. Abdominal computed tomography revealed scattered colonic diverticula, but otherwise showed no abnormalities. A colonoscopy was performed to evaluate her symptoms, revealing erythema and loss of vascularity in a continuous and circumferential pattern from the anus to the rectum, consistent with proctitis. The rest of the colon appeared normal. Multiple biopsies were taken from the colon and the proctitis area. Pathology revealed a focal increase in mast cells in the lamina propria, with up to 40 mast cells per high-power field (HPF) detected by CD117 immunostaining. Due to concerns for MCAS in the context of unexplained anaphylaxis and colonoscopy findings, the patient was started on famotidine to assess therapeutic response. At a 2-month follow-up, she reported complete resolution of diarrhea and abdominal pain. Discussion: Diagnosing MCAS requires meeting 3 criteria: symptoms of mast cell activation, objective evidence of increased mast cell mediators during episodes, and a response to treatment with anti-mediator therapy. In our case, the patient met 2 criteria, and normal tryptase levels were likely due to sampling timing outside the anaphylactic episode. Management includes avoiding triggers and using medications like antihistamines. Our patient responded well to an antihistamine, supporting the MCAS diagnosis. Colonoscopy findings in MCAS are typically nonspecific, with proctitis being a rare presentation. Our case highlights the importance of considering mast cell disorders like MCAS in patients with a history of anaphylaxis presenting with diarrhea and abdominal pain.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001143416.66580.04
Primary Topic
Mast cells and histamine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S3989 Proctitis as an Unusual Presentation of Mast Cell Activation Syndrome

Obada Daaboul, Muhammed Yaman Swied, Muaataz Azzawi, Abdul Swied
The American Journal of Gastroenterology
Mast cells and histamine
article

S3989 Proctitis as an Unusual Presentation of Mast Cell Activation Syndrome

Obada Daaboul, Muhammed Yaman Swied, Muaataz Azzawi, Abdul Swied
article en

Abstract

Introduction: Mast cell activation syndrome (MCAS) is a condition characterized by the excessive activation of mast cells, leading to the release of mediators such as histamine, tryptase, and prostaglandins. MCAS typically affects at least 2 systems, including dermatologic (flushing, urticaria, pruritus), gastrointestinal (abdominal pain, diarrhea, nausea), cardiovascular (hypotension, tachycardia, syncope), and respiratory (wheezing, dyspnea). We present an interesting case of MCAS with an unusual presentation of proctitis on endoscopy, where symptoms resolved with antihistamine therapy. Case Description/Methods: A 52-year-old woman with a history of multiple episodes of anaphylaxis of unclear etiology presented to the clinic for evaluation of abdominal pain and diarrhea that had persisted for one year. Abdominal computed tomography revealed scattered colonic diverticula, but otherwise showed no abnormalities. A colonoscopy was performed to evaluate her symptoms, revealing erythema and loss of vascularity in a continuous and circumferential pattern from the anus to the rectum, consistent with proctitis. The rest of the colon appeared normal. Multiple biopsies were taken from the colon and the proctitis area. Pathology revealed a focal increase in mast cells in the lamina propria, with up to 40 mast cells per high-power field (HPF) detected by CD117 immunostaining. Due to concerns for MCAS in the context of unexplained anaphylaxis and colonoscopy findings, the patient was started on famotidine to assess therapeutic response. At a 2-month follow-up, she reported complete resolution of diarrhea and abdominal pain. Discussion: Diagnosing MCAS requires meeting 3 criteria: symptoms of mast cell activation, objective evidence of increased mast cell mediators during episodes, and a response to treatment with anti-mediator therapy. In our case, the patient met 2 criteria, and normal tryptase levels were likely due to sampling timing outside the anaphylactic episode. Management includes avoiding triggers and using medications like antihistamines. Our patient responded well to an antihistamine, supporting the MCAS diagnosis. Colonoscopy findings in MCAS are typically nonspecific, with proctitis being a rare presentation. Our case highlights the importance of considering mast cell disorders like MCAS in patients with a history of anaphylaxis presenting with diarrhea and abdominal pain.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 65%
Mast cells and histamine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.